News | Site Map | E-reporting
  Home Corporate Profile Business Divisions Products Careers Contacts Feedback
    
Year           Event
1974
Incorporated as a Private Limited Company
1983 Starts full fledged production at Pimpri Plant
1984 Quality Excellence Award from Indian Manufacturers Association
1986 Shares listed on Bombay Stock Exchange
1986 Quality Excellence Award from Indian Manufacturers Association
1988 Industrial Safety Performance Award
1992 Starts manufacturing exclusive Animal Food Supplement facilities
1993 Entry in International Market
1997
Starts manufacturing exclusive for Anti-Tuberculosis (Anti-TB) Product Range
1998
Li Taka acquires Marketing Division of Borachem Industries Ltd.
1999
Loan License Agreement with Herbalife International India Pvt. Ltd. (A subsidiary of Herbalife USA), exclusive dietary food.
2000
Li Taka moves up from 177th position to 135th position on ORG Survey of 250 Top ranked Indian Pharma Companies.
2001
Company goes through Management change and Mr. Rajendra Bora takes over as Chairman & Managing Director
2001
Awarded Anti-TB Tender of $3 million (Rs.15 Crores) by Novartis India Ltd. for World Bank.
2002
Li Taka register a prescription growth of 40% for second consecutive year as per ORG survey
2003
Awarded $5.5 million (Rs.25 Crores) Tender by Novartis India Ltd. for World Bank.
Awarded $100,000 (Rs.50 Lacs) Tender in Uganda by Anti-Aids Committee
2004
Li Taka completes registration of branded products in 20 countries.
2006
Care Unipac Pvt. Ltd., merged with the company, Mr. Gopal Ramourti takes over as the Managing Director. 
2009
The Hon'ble Bombay High Court has passed the order for approving the Scheme of Arrangement of        Twilight Litaka Pharma Ltd. & Twilight Mercantiles Ltd.
Twilight Litaka Pharma Ltd. had acquired the Marketing Division and the Manufacturing Plant situated at Baddi-Himachal Pradesh.
2010 Company listed on National Stock Exchange
Home | Corporate Profile | Business Divisions | Products | Careers | Contacts | Feedback
Copyright © Twilight Litaka Pharma Ltd.